Skip to content
OpenSampling

2025 · Frontiers in cellular and infection microbiology · open access

Evolving HPV diagnostics: current practice and future frontiers

Shi et al.

The finding, in our words

This review summarises how emerging HPV detection methods including CRISPR/Cas systems, droplet digital PCR and isothermal amplification, combined with self-collected vaginal swabs and liquid biopsy from urine or blood, could improve screening acceptability and enable point-of-care testing compared with conventional approaches that require invasive sampling and centralised laboratory infrastructure.

A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.

Labels

  1. 2023

    First-void urine is established as a reliable self-collected specimen for human papillomavirus screening, triage, and post-vaccination surveillance. The use of specialised collection devices and advanced molecular assays supports the integration of non-invasive sampling into routine cervical cancer prevention strategies.

    Testing for Human Papillomaviruses in Urine, Blood, and Oral Specimens: an Update for the LaboratoryPoljak et al., Journal of clinical microbiology · source ↗

    • first-void
    • blood
    • sti
    • self-collection
    • hpv
    • liquid-biopsy
    • urine
    • validation
    • saliva
  2. 2024

    This literature review found that DNA methylation markers on self-collected urine or cervicovaginal swabs detected cervical intraepithelial neoplasia as well as cytology. The combination could improve screening uptake and reduce loss to follow-up, particularly in low- and middle-income countries, though more evidence is needed to identify the most efficacious methylation tests.

    The current state of DNA methylation biomarkers in self-collected liquid biopsies for the early detection of cervical cancer: a literature reviewSumiec et al., Infectious agents and cancer · source ↗

    • urine
    • self-collection
    • validation
    • hpv
    • sti
    • biomarkers
    • liquid-biopsy
  3. 2026

    This meta-analysis found that HPV testing using self-collected vaginal and urine samples showed sensitivities of 88.6% and 81% for detecting cervical precancer. Using a standardised device for first-void urine increased sensitivity to 86.6%, supporting decentralised patient-centric screening, though data on specificity and specific commercial devices were not consistently reported.

    Diagnostic Performance of HPV Testing Using Self-Collected Urine and Vaginal Samples for Detecting Cervical Precancer or Worse: A Meta-AnalysisHsiao et al., The journal of obstetrics and gynaecology research (paywalled) · source ↗

    • urine
    • first-void
    • self-collection
    • validation
    • hpv
    • sti
  4. 2026

    This meta-analysis found that self-collected urine samples for HPV testing had lower sensitivity for detecting high-grade lesions compared to physician-collected cervical specimens. The use of a first-void collection device such as Colli-Pee was associated with marginally higher sensitivity than general urine sampling.

    Accuracy of HPV Testing Using Self-collected Urine Compared With Physician-collected Cervical Specimen for HSIL or WorseChen et al., Journal of lower genital tract disease (paywalled) · source ↗

    • urine
    • first-void
    • colli-pee
    • self-collection
    • validation
    • hpv
    • sti
  5. 2026

    Vaginal self-sampling achieved higher pooled sensitivity and specificity than urine self-sampling for detecting high-risk HPV, making it the preferred option, while urine self-sampling remains a useful non-invasive choice for under-screened populations.

    Diagnostic Accuracy of Urine and Vaginal Self-Sampling for Detection of High-Risk Human Papillomavirus: A Systematic Review and Meta-AnalysisRakhat & Aimagambetova, Viruses · source ↗

    • first-void
    • sti
    • self-collection
    • hpv
    • urine
    • validation